Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310

NCT01560637 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT01560637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01560637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Lead sponsor
United Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
September 11, 2013
Completion date
August 12, 2021
Enrollment
471 (actual)
Sites
153

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension